Synergistic Effect of Norepinephrine Transporter Blockade and &agr;-2 Antagonism on Blood Pressure in Autonomic Failure

No abstract is available for this paper.

• Publication year

  2012

• Venue

  HYPERTENSION

• Publication date

  2012-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/HYPERTENSIONAHA.111.184812PMID 22311903PMCID PMC3312003
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacotherapy of autonomic failure.

  2012cited by this paper
• The Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom assessment scale

  2012cited by this paper
• Cardiovascular Effects of Methylphenidate, Amphetamines and Atomoxetine in the Treatment of Attention-Deficit Hyperactivity Disorder

  2010cited by this paper
• Comparative Efficacy of Yohimbine Against Pyridostigmine for the Treatment of Orthostatic Hypotension in Autonomic Failure

  2010cited by this paper
• 9-alpha-fluorohydrocortisone in the treatment of postural hypotension.

  2009cited by this paper
• Generalized and neurotransmitter‐selective noradrenergic denervation in Parkinson's disease with orthostatic hypotension

  2008cited by this paper
• Norepinephrine Transporter Blockade With Atomoxetine Induces Hypertension in Patients With Impaired Autonomic Function

  2007cited by this paper
• Influences of Norepinephrine Transporter Function on the Distribution of Sympathetic Activity in Humans

  2006cited by this paper
• Neuropharmacologic Distinction of Neurogenic Orthostatic Hypotension Syndromes

  2006cited by this paper
• Paradoxical effect of sibutramine on autonomic cardiovascular regulation in obese hypertensive patients

  2005cited by this paper
• Atomoxetine Hydrochloride: Clinical Drug-Drug Interaction Prediction and Outcome

  2004cited by this paper
• Human sympathetic activation by alpha2-adrenergic blockade with yohimbine: Bimodal, epistatic influence of cytochrome P450-mediated drug metabolism.

  2004cited by this paper
• Selective Impairment in Sympathetic Vasomotor Control With Norepinephrine Transporter Inhibition

  2003cited by this paper
• Identification of the human cytochromes P450 responsible for atomoxetine metabolism.

  2002cited by this paper
• The nature of the autonomic dysfunction in multiple system atrophy.

  2002cited by this paper
• Sympathetically mediated hypertension in autonomic failure.

  2000cited by this paper
• Autoregulation of cerebral blood flow in orthostatic hypotension.

  1998cited by this paper
• Contrasting actions of pressor agents in severe autonomic failure.

  1998cited by this paper
• N(N)-nicotinic blockade as an acute human model of autonomic failure.

  1998cited by this paper
• Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group.

  1997cited by this paper
• Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy

  1996cited by this paper
• Manipulation of Norepinephrine Metabolism with Yohimbine in the Treatment of Autonomic Failure

  1994cited by this paper
• Effects of desipramine on sympathetic nerve firing and norepinephrine spillover to plasma in humans.

  1991cited by this paper
• Central sympathoinhibition and peripheral neuronal uptake blockade after desipramine in rabbits.

  1991cited by this paper
• Yohimbine increases sympathetic nerve activity and norepinephrine spillover in normal volunteers.

  1991cited by this paper
• Effect of food intake on cardiovascular control in patients with impaired autonomic function.

  1990cited by this paper
• Effects of desipramine hydrochloride on peripheral sympathetic nerve activity.

  1990cited by this paper
• Effect of yohimbine on blood pressure in patients with depression and orthostatic hypotension induced by clomipramine

  1989cited by this paper
• Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans.

  1988cited by this paper
• Modulation of Noradrenaline Release by Peripheral Presynaptic α2‐Adrenoceptors in Humans

  1987cited by this paper
• Modulation of noradrenaline release by peripheral presynaptic alpha 2-adrenoceptors in humans.

  1987cited by this paper
• Oral yohimbine in human autonomic failure

  1987cited by this paper
• Use of alpha 2 adrenoreceptor agonists and antagonists in the functional assessment of the sympathetic nervous system.

  1986cited by this paper
• Isolated failure of autonomic noradrenergic neurotransmission. Evidence for impaired beta-hydroxylation of dopamine.

  1986cited by this paper
• Disorders of the Autonomic Nervous System

  1966cited by this paper

• Update on the Treatment of Autonomic Disorders

  2025cites this paper
• Intersection of Autonomic Dysfunction and Parkinson’s Disease: Insights Into Neurogenic and Classical Orthostatic Hypotension

  2025cites this paper
• Peripheral autonomic failure is associated with more severe postprandial hypotension compared to central autonomic failure

  2025cites this paper
• Treating Lows: Management of Orthostatic Hypotension

  2024cites this paper
• Norepinephrine Reuptake Inhibition, an Emergent Treatment for Neurogenic Orthostatic Hypotension

  2024cites this paper
• David Herlie Robertson, MD.

  2024cites this paper
• Atomoxetine for Intradialytic Hypotension in a Patient on Hemodialysis: A Case Report

  2024cites this paper
• Cardiovascular dysautonomia and cognitive impairment in Parkinson's disease (Review)

  2024cites this paper
• Atomoxetine on neurogenic orthostatic hypotension: a randomized, double-blind, placebo-controlled crossover trial

  2024cites this paper
• Effects of Atomoxetine for the Treatment of Neurogenic Orthostatic Hypotension in Patients With Alpha-synucleinopathies: A Systematic Review of Randomized Controlled Trials and a Focus-Group Discussion

  2023cites this paper
• Non-pharmacological and drug treatment of autonomic dysfunction in multiple system atrophy: current status and future directions

  2023cites this paper
• Continuous Positive Airway Pressure for the Treatment of Supine Hypertension and Orthostatic Hypotension in Autonomic Failure

  2023cites this paper
• Orthostatic Hypotension: Management of a Complex, But Common, Medical Problem

  2022cites this paper
• New approaches to treatments for sleep, pain and autonomic failure in Parkinson's disease - Pharmacological therapies.

  2022cites this paper
• Clinical Trials In Parkinson's Disease

  2021cites this paper
• Local Passive Heat for the Treatment of Hypertension in Autonomic Failure

  2021cites this paper
• Clinical Trials for Orthostatic Hypotension in Parkinson’s Disease and Other Synucleinopathies

  2021cites this paper
• Orthostatic Hypotension in Older Adults

  2021cites this paper
• Clinical Trials for Neurogenic Orthostatic Hypotension: A Comprehensive Review of Endpoints, Pitfalls, and Challenges

  2020cites this paper
• Prevention and Treatment

  2020cites this paper
• Orthostatic Hypotension in Parkinson Disease.

  2020cites this paper
• State-of-the-art pharmacotherapy for autonomic dysfunction in Parkinson’s disease

  2020cites this paper
• Management of Orthostatic Hypotension.

  2020cites this paper
• Cardiovascular Safety Considerations in the Treatment of Neurogenic Orthostatic Hypotension.

  2020cites this paper
• Pharmacologic treatment of orthostatic hypotension.

  2020cites this paper
• Hypertension and QT interval prolongation associated with targeted systemic cancer therapies

  2020cites this paper
• Orthostatic hypotension. Part 2: diagnosis and treatment

  2020cites this paper
• for Orthostatic in Parkinson’s and Other

  2020cites this paper
• Orthostatic hypotension in Parkinson disease

  2019cites this paper
• Synergistic Pressor Effect of Atomoxetine and Pyridostigmine in Patients With Neurogenic Orthostatic Hypotension

  2019cites this paper
• Efficacy of atomoxetine versus midodrine for neurogenic orthostatic hypotension

  2019cites this paper
• Clinical neurophysiology of multiple system atrophy.

  2019cites this paper
• Orthostatic Hypotension: JACC State-of-the-Art Review.

  2018cites this paper
• Chemical pharmacotherapy for the treatment of orthostatic hypotension

  2018cites this paper
• Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies

  2018cites this paper
• Polypharmacy: droxidopa to treat neurogenic orthostatic hypotension in a patient with Parkinson disease and type 2 diabetes mellitus

  2017cites this paper
• Correction to: Evidence-based treatment of neurogenic orthostatic hypotension and related symptoms

  2017influential citation
• Factors Influencing the Cardiovascular Response to Subanesthetic Ketamine: A Randomized, Placebo-Controlled Trial

  2017cites this paper
• Evidence-based treatment of neurogenic orthostatic hypotension and related symptoms

  2017cites this paper
• Efficacy of Servo-Controlled Splanchnic Venous Compression in the Treatment of Orthostatic Hypotension: A Randomized Comparison With Midodrine

  2016influential citation
• Neurogenic orthostatic hypotension: roles of norepinephrine deficiency in its causes, its treatment, and future research directions

  2015cites this paper
• Current Pharmacological Management of Hypotensive Syndromes in the Elderly

  2015cites this paper
• Clinical Relevance of Orthostatic Hypotension in Neurodegenerative Disease

  2015cites this paper
• Combination ergotamine and caffeine improves seated blood pressure and presyncopal symptoms in autonomic failure

  2014cites this paper
• A standing dilemma: autonomic failure preceding Hodgkin's lymphoma.

  2014cites this paper
• Nebivolol, But Not Metoprolol, Lowers Blood Pressure in Nitric Oxide–Sensitive Human Hypertension

  2014cites this paper
• Management of orthostatic hypotension in patients with Parkinson's disease

  2014cites this paper
• Neurogenic orthostatic hypotension in Parkinson’s disease: evaluation, management, and emerging role of droxidopa

  2014cites this paper
• Orthostatic Hypotension and Supine Hypertension in the Patient with Autonomic Failure

  2014cites this paper
• Management of Neurogenic Orthostatic Hypotension in Patients with Autonomic Failure

  2013cites this paper
• Current Concepts in Orthostatic Hypotension Management

  2013cites this paper
• New therapies for postural hypotension.

  2012cites this paper
• Update on the theory and management of orthostatic intolerance and related syndromes in adolescents and children

  2012cites this paper
• Vascular Health and Risk Management Dovepress Neurogenic Orthostatic Hypotension in Parkinson's Disease: Evaluation, Management, and Emerging Role of Droxidopa

  year unknowncites this paper